Amneal Biosciences:
Founded on
a passion for
helping patients
It’s all about value
We are focused on providing high-quality, affordable medicines
1994: Discovering
Starting as a pharmacist, Co-Founder & Co-Chief Executive Officer of Amneal Pharmaceuticals, Chintu Patel, discovered a new purpose.
“Patients shouldn’t have to choose between
affording food or medicine.”
2002: Establishing
Chintu teamed up with his brother, Chirag, to found Amneal Pharmaceuticals.
2005: Manufacturing
Amneal produces its first generic prescription drug.
2006-2011: Building
Amneal becomes one of the largest generics companies in the United States.
2014: Evolving
Amneal Biosciences* is formed.
“Our high-quality, affordable biosimilar options enhance the
sustainability of the oncology supply chain.”
2018: Initial Public Offering
The Amneal IPO in May 2018 provided the foundation for continued growth and innovation.
2022: Emerging
Our biosimilar products help to create a more sustainable healthcare system by offering affordable and high-quality treatment options.
*Amneal Biosciences is a division within Amneal’s Generics segment, which is a part of Amneal Pharmaceuticals LLC.
Hear from the founders about how Amneal Biosciences grew from humble beginnings into the global leader of affordable, sophisticated medicines it is today.
